LivaNova (LIVN) Current Deferred Tax Assets (2015)
LivaNova's (LIVN) quarterly Current Deferred Tax Assets came in at $4.4 million in Q4 2015, down 39.14% quarter-over-quarter from $7.2 million in Q2 2015.
Analysis
LivaNova (LIVN) Current Deferred Tax Assets (2015) Analysis & Trends
LivaNova has disclosed Current Deferred Tax Assets across 1 years of filings, most recently posting $4.4 million for Q4 2015.
- In Q4 2015, Current Deferred Tax Assets changed N/A year-over-year to $4.4 million; the TTM figure through Oct 2015 stood at $4.4 million (changed N/A YoY), while the FY2015 annual figure was $7.2 million, changed N/A from the prior year.
- Current Deferred Tax Assets came in at $4.4 million for Q4 2015 at LivaNova, down from $7.2 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $7.2 million in Q2 2015 to a low of $4.4 million in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn |